Close Menu

NEW YORK – Fluidigm said on Tuesday that it has signed a distribution deal with De Novo Software to offer that firm's data-analysis tools alongside Fluidigm's mass cytometer platforms.

Under the agreement, new purchases of Fluidigm's Helios mass cytometer and Hyperion imaging system will include a one-year license for De Novo's FCS Express 7 Flow software for suspension data analysis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.